Day: July 8, 2020

Weyland Tech’s AtozGo Partners with Global Fintech Provider for Food Delivery Service in Jakarta

Written by Customer Service on July 8, 2020. Posted in Public Companies.

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) — Weyland Tech, Inc. (OTCQX: WEYL), a leading global provider of eCommerce, mCommerce and fintech business enablement solutions, has partnered with an NYSE-traded global consumer internet company to offer its AtozGo™ food and grocery delivery service to the partner’s large and growing fintech user base in Jakarta, Indonesia.Access to the AtozGo delivery service, which is currently available for both office and residential customers, will be integrated into the partner’s mobile e-wallet app, allowing users to transact AtozGo orders within the app. Through this integration, AtozGo will gain access to the hundreds of thousands of merchants and millions of users already on the partner’s platform.This will represent the partner’s foray into the food and grocery delivery market in Southeast Asia....

Recce Pharmaceuticals Announces RECCE® Compounds Selected by CSIRO/Doherty Institute in Priority 1 Candidate Group for SARS-CoV-2 Antiviral Screening Program

Written by Customer Service on July 8, 2020. Posted in Public Companies.

Highlights:RECCE® 327 and New RECCE® 529 compounds were selected for their unique mechanisms of action against hyper-mutation, as indicated on bacteria and viruses (respectively)Testing program will be conducted by CSIRO & University of Melbourne at the Doherty InstituteTherapeutic antiviral treatment focus of RECCE® 327 and RECCE® 529 may see added potential benefit against secondary bacterial infectionsSYDNEY, Australia, July 08, 2020 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced it has entered into an Antiviral SARS-CoV-2 Screening Program Agreement with The Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the University of Melbourne at The Peter Doherty Institute for Infection and Immunology (‘Doherty...

Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

Written by Customer Service on July 8, 2020. Posted in Public Companies.

Dr. Golumbeski formerly led corporate and business development at Celgene and NovartisAppointment adds unique skill set to Corbus Board ahead of several key data readouts this summerNorwood, MA, July 08, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors.During his corporate career, Dr. Golumbeski held senior leadership positions in business development at Celgene, Novartis, Elan Pharmaceuticals and Schwarz Pharma. In these roles, he drove business strategies that created value, fostered internal and external collaboration, and built creative deal structures and teams...

Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic

Written by Customer Service on July 8, 2020. Posted in Public Companies.

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). The agreement covers the United States, Canada, Japan, and Europe.“Studies continue to show that the full promise of personalized medicine remains out of reach for the majority of patients with advanced non-small cell lung cancer who are not receiving complete genotyping before starting therapy, thus impeding their treatment with the most appropriate therapy,” said AmirAli Talasaz, Ph.D., Guardant Health President. “Our Guardant360...

Systematic Sampling at Novo’s Egina Mining Lease Yields Positive ‘MAK’ Gold Results

Written by Customer Service on July 8, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to report positive mobile alluvial Knudson (“MAK”) sampling results from across its 100% owned Egina mining lease, M47/560, indicating widespread gold potential within terrace gravels. The Egina mining lease is a small part of the Company’s overall terrace holdings, representing approximately 5 sq km out of nearly 2,500 sq km, but these systematic sample results provide an encouraging picture of how gold might prove to be distributed over broader parts of the project. Novo’s 2020 Egina exploration program is now ramped back up to full capacity.Summary:MAK sampling has continued apace since Novo resumed its 2020 field season a few weeks ago following a minor delay resulting from COVID-19...

XPO Logistics Schedules Second Quarter 2020 Earnings Conference Call for Friday, July 31, 2020

Written by Customer Service on July 8, 2020. Posted in Public Companies.

GREENWICH, Conn., July 08, 2020 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO) will hold its second quarter conference call and webcast on Friday, July 31, at 8:30 a.m. Eastern Time. The company’s results will be released after market close on July 30 and made available on www.xpo.com.Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at: www.xpo.com/investorsA replay of the conference call will be available until August 31, 2020, by calling toll-free (from US/Canada) 1-877-660-6853; international callers dial +1-201-612-7415. Use the passcode 13706704. Additionally, the call will be archived on www.xpo.com/investors.About XPO LogisticsXPO Logistics, Inc. (NYSE: XPO) is a top ten global logistics provider of cutting-edge supply chain solutions to the...

Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies

Written by Customer Service on July 8, 2020. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif. and MONROVIA, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, and Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that the companies have entered into a collaboration and license agreement to research, develop and commercialize T cell-engaging bispecific antibodies as potential therapeutics in oncology.Bispecific antibodies that direct T cells to tumor cells, by simultaneously binding CD3 on T cells and a target on tumor cells, have the potential to drive...

Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2020

Written by Customer Service on July 8, 2020. Posted in Earnings Releases And Operating Results.

MINNEAPOLIS, July 08, 2020 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the third quarter of fiscal 2020. Third quarter fiscal 2020 financial and operating results include (with growth rates compared to third quarter fiscal 2019 results): Consolidated net sales decreased 34.6% to $9,745,000ZERUST® industrial product net sales decreased 24.1% to $6,258,000ZERUST® oil and gas net sales decreased 51.9% to $425,000NTIC China product net sales decreased 16.3% to $3,089,000Natur-Tec® product net sales decreased 50.4% to $2,388,000Joint venture operating income decreased 49.0% to $1,688,000Operating expenses declined 10.2% to $5,651,000NTIC...

Forescout Technologies Announces Preliminary Second Quarter 2020 Revenue

Written by Customer Service on July 8, 2020. Posted in Earnings Releases And Operating Results.

SAN JOSE, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Forescout Technologies, Inc. (NASDAQ:FSCT), the leader in device visibility and control, today announced preliminary unaudited results for its second quarter ended June 30, 2020, based upon preliminary unaudited financial information.Total revenue for the second quarter is expected to be in the range of $78 million – $82 million, up 40% quarter-over-quarter at the midpoint of the range. Within this, the company anticipates license revenue from sales of one-year term-based licenses to be in excess of 35% of all license revenue.During the second quarter, Forescout closed strategic deals with both new and existing customers and demonstrated strong traction on its plan of building a more predictable revenue stream through sales of term-based licenses and other subscription offerings. Michael...

HCI Group Declares Q3 2020 Quarterly Cash Dividend

Written by Customer Service on July 8, 2020. Posted in Dividend Reports And Estimates.

TAMPA, Fla., July 08, 2020 (GLOBE NEWSWIRE) — The board of directors of HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, has declared a regular quarterly cash dividend in the amount of 40 cents per common share for the third quarter of 2020. The dividend will be paid September 18, 2020 to shareholders of record on the close of business August 21, 2020.About HCI Group, Inc.HCI Group, Inc. is an InsurTech company with operations in insurance, software development and real estate. HCI’s leading insurance operation, TypTap Insurance Company, is a rapidly growing, technology-driven insurance company, which provides homeowners’ insurance and flood insurance primarily in Florida. TypTap’s operations are powered in large part by insurance-related information technology...

Day: July 8, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals